Adagio Medical (Nasdaq:ADGM) announced today that it received FDA breakthrough device designation for its vCLAS cryoablation system. The Laguna Hills, California-based company based its vCLAS cryoablation catheter on its proprietary ultra-low cryoablation technology (ULCT). It aims to address the challenges of ventricular tachycardia (VT) … [Read more...] about Adagio Medical wins FDA breakthrough nod for cryoablation tech
Adagio Medical
Adagio Medical to restructure, reduce workforce
Adagio Medical (Nasdaq:ADGM) announced today that it plans a corporate restructuring and realignment of resources. The Laguna Hills, California–based company, which develops catheter ablation technologies for treating cardiac arrhythmias, wants to prioritize its FULCRUM-VT pivotal FDA investigational device exemption (IDE) clinical trial … [Read more...] about Adagio Medical to restructure, reduce workforce
Adagio Medical picks medtech veteran Todd Usen as new CEO
Adagio Medical (Nasdaq:ADGM) announced today that it appointed Todd Usen as its new CEO and board director. Usen's appointment follows the departure of Olav Bergheim, the company's founder, CEO and board chair, effective Dec. 13. The company concurrently made Usen CEO and Orly Mishan chair of the board of directors. Bergheim intends to continue … [Read more...] about Adagio Medical picks medtech veteran Todd Usen as new CEO
Ablation tech developer Adagio Medical to go public in SPAC deal
Arya Sciences Acquisition Corp IV agreed to a business combination with Adagio Medical, taking the cardiac ablation company public. Upon the closing of the transaction, Adagio is set to become a subsidiary of Aja Holdco, still operating under its existing management team and under the name "Adagio Medical." Arya expects to list the combined … [Read more...] about Ablation tech developer Adagio Medical to go public in SPAC deal
